stockrowWarby Parker Inc.
WRBY Healthcare Medical Instruments & Supplies
Warby Parker Inc.’s revenue for fiscal 2025 (year ended December 2025) was $871.9 million, up 13.0% from fiscal 2024.
- Revenue
- +10.4%
- EPS
- −20.0%
- Free cash flow
- −30.3%
Quarter to September 2026, against a year earlier
Follow WRBY
Alert me
Warby Parker Inc. (WRBY) Net income
Warby Parker Inc.'s net income for fiscal 2025 was $1.6M, compared with −$20.4M in fiscal 2024. Over the twelve months to 30 September 2026 it was $7.5M. Over the past ten years it has ranged from −$144.3M (fiscal 2021) to $1.6M (fiscal 2025) — the current reading is the highest in ten years. Net income has risen for 4 consecutive fiscal years. Warby Parker Inc. ranks 24th of 51 Medical Instruments & Supplies companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | $1.6M | — |
| FY2024 | −$20.4M | — |
| FY2023 | −$63.2M | — |
| FY2022 | −$110.4M | — |
| FY2021 | −$144.3M | — |
| FY2020 | −$55.9M | — |
| FY2019 | $0.00 | — |
| FY2017 | $0.00 | — |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Sep 2026 | $5.6M | 20.65% |
| Jun 2026 | $4.6M | 46.18% |
| Mar 2026 | $3.2M | — |
| Dec 2025 | −$6.0M | — |
| 23 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| STVN Stevanato Group S.p.A. compare | $227.4M |
| LMAT LeMaitre Vascular, Inc. compare | $63.3M |
| ICUI ICU Medical, Inc. compare | $60.3M |
| ATRC AtriCure, Inc. compare | $14.9M |
| WRBY Warby Parker Inc. | $7.5M |
| PLSE Pulse Biosciences, Inc compare | −$83.8M |
| XRAY DENTSPLY SIRONA Inc. compare | −$122.0M |
| AZTA Azenta, Inc. compare | −$122.9M |
| KMTS Kestra Medical Technologies, Ltd. compare | −$149.9M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on WRBY
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement